Adenocarcinoma of the Gastroesophageal Junction: Benefits of an Extended Lymphadenectomy

Surgical Oncology Clinics of North America

Volumn 15, Issue 4, 2006, Pages 765-780

  Williams, Valerie A ^a   Peters, Jeffrey H ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EARLY CANCER; EN BLOC ESOPHAGOGASTRECTOMY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; GASTROESOPHAGUS ADENOCARCINOMA; GASTROINTESTINAL CARCINOMA; HUMAN; INTERMETHOD COMPARISON; LYMPHADENECTOMY; OUTCOME ASSESSMENT; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TRANSHIATAL ESOPHAGOGASTRECTOMY; TUMOR LOCALIZATION; UNITED STATES;

ADENOCARCINOMA; CARDIA; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; HUMANS; LYMPH NODE EXCISION;

EID: 33749363075     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2006.07.009     Document Type: Review

References (36)

1. American Cancer Society. Cancer facts and figures 2005. Available at: http://www.cancer.org. Accessed September 29, 2005.
2. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 11 (1999) 825-831
3. Nigro J., Hagen J.A., DeMeester T.R., et al. Occult esophageal adenocarcinoma-extent of disease and implications for effective therapy. Ann Surg 230 3 (1999) 433-440
4. van Sandick J.W., van Lanschot J.J.B., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
5. Portale G., Peters J.H., Hsiesh C.C., et al. Esophageal adenocarcinoma in patients [less-than or equal to] 50 years old: delayed diagnosis and advanced disease at presentation. Am Surg 70 11 (2004) 954-958
6. Ohga T., Kimura Y., Futatsugi M., et al. Surgical and oncological advances in the treatment of esophageal cancer. Surgery 131 (2002) S28-S34
7. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 (1993) 510-513
8. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
9. Nigro J.J., Hagen J.A., DeMeester T.R., et al. Prevalence and location of nodal metastasis in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J Thorac Cardiovasc Surg 117 (1999) 16-25
10. Clark G.W., Peters J.H., Ireland A.P., et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 58 (1994) 646-653
11. Nigro J.J., DeMeester S.R., Hagen J.A., et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 117 (1999) 960-968
12. Hulscher J.B., van Sandick J.W., Tijssen J.G., et al. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191 2 (2000) 143-148
13. Becker C.D., Barbier P.A., Terrier F., et al. Patterns of recurrence of esophageal carcinoma after transhiatal esophagectomy and gastric interposition. AJR Am J Roentgenol 148 2 (1987) 273-277
14. Gignoux M., Roussel A., Paillot B., et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11 4 (1987) 426-432
15. Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16 6 (1992) 1104-1109
16. Matsubara T., Ueda M., Yanagida O., et al. How extensive should lymph node dissection be for cancer of the thoracic esophagus?. J Thorac Cardiovasc Surg 107 4 (1994) 1073-1078
17. Altorki N., and Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma?. Ann Surg 234 5 (2001) 581-587
18. Hagen J.A., DeMeester S.R., Peters J.H., et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234 4 (2001) 520-530
19. Collard J.M., Otte J.B., Fiasse R., et al. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 234 1 (2001) 25-32
20. Swanson S.J., Batirel H.F., Bueno R., et al. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma. Ann Thorac Surg 72 6 (2001) 1918-1924
21. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
22. Apinop C., Puttisak P., and Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41 (1994) 391-393
23. Le Prise E., Etienne P., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1779-1784
24. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
25. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemo-radiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
26. Urba S., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional carcinoma. J Clin Oncol 19 (2001) 305-313
27. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359 (2002) 1727-1733
28. Johansson J.J., DeMeester T.R., Hagen J.A., et al. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus. Arch Surg 139 (2004) 627-633
29. Hagen J.A., Peters J.H., and Demeester T.R. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 106 (1993) 850-858
30. Putnam Jr. J.B., Suell D.M., McMurtrey M.J., et al. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 57 2 (1994) 319-325
31. Horstmann O., Verreet P.R., Becker H., et al. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of oesophageal cancer. Eur J Surg 161 8 (1995) 557-567
32. Altorki N.K., Girardi L., and Skinner D.B. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg 114 6 (1997) 948-955
33. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 21 (2002) 1662-1669
34. Sihvo E.L., Luostarinen M.E., and Salo J.A. Fate of patients with adenocarcinoma of the esophagus and esophagogastric junction: A population based analysis. Am J Gastroenterol 99 (2004) 419-424
35. Orringer M.B., Marshall B., and Stirling M.C. Transhiatal esophagectomy for benign and malignant disease. J Thorac Cardiovasc Surg 105 2 (1993) 265-276
36. Rentz J., Bull D., Harpole D., et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 125 5 (2003) 1114-1120